Are ipsilateral breast tumour invasive recurrences in young (< or =40 years) women more aggressive than their primary tumours?

about

Are ipsilateral breast tumour invasive recurrences in young (< or =40 years) women more aggressive than their primary tumours?

Item

http://www.wikidata.org/entity/Q36611405

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Are ipsilateral breast tumour ...... ve than their primary tumours?

@ast

Are ipsilateral breast tumour ...... ve than their primary tumours?

@en

type

Item

label

Are ipsilateral breast tumour ...... ve than their primary tumours?

@ast

Are ipsilateral breast tumour ...... ve than their primary tumours?

@en

prefLabel

Are ipsilateral breast tumour ...... ve than their primary tumours?

@ast

Are ipsilateral breast tumour ...... ve than their primary tumours?

@en

P1476

Are ipsilateral breast tumour ...... ve than their primary tumours?

@en

P2093

Antoni G

http://www.w3.org/2001/XMLSchema#string

Bollet MA

http://www.w3.org/2001/XMLSchema#string

Fourquet A

http://www.w3.org/2001/XMLSchema#string

Pierga JY

http://www.w3.org/2001/XMLSchema#string

Salmon R

http://www.w3.org/2001/XMLSchema#string

Savignoni A

http://www.w3.org/2001/XMLSchema#string

Sigal-Zafrani B

http://www.w3.org/2001/XMLSchema#string

P2860

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials

Interobserver reproducibility of the Nottingham modification of the Bloom and Richardson histologic grading scheme for infiltrating ductal carcinoma.

Determination of the molecular relationship between multiple tumors within one patient is of clinical importance.

True recurrence vs. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management.

Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation.

Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer.

Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences.

Predicting a local recurrence after breast-conserving therapy by gene expression profiling.

Histological grading of breast carcinomas: a study of interobserver agreement.

P2888

sj.bjc.6603991

P304

1046-1052

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6603991

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Anne Vincent-Salomon

Xavier Sastre-Garau

P577

2007-09-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5967359

http://www.w3.org/2001/XMLSchema#string

P698

17876326

http://www.w3.org/2001/XMLSchema#string

P932

2360440

http://www.w3.org/2001/XMLSchema#string